These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 9708519

  • 1. Radiotoxicity of iodine-125-labeled oligodeoxyribonucleotides in mammalian cells.
    Sedelnikova OA, Panyutin IG, Thierry AR, Neumann RD.
    J Nucl Med; 1998 Aug; 39(8):1412-8. PubMed ID: 9708519
    [Abstract] [Full Text] [Related]

  • 2. Cell killing induced by decay of 125I during the cell cycle: comparison of 125I-antipyrine with 125I-bovine serum albumin.
    Miyazaki N, Shinohara K.
    Radiat Res; 1993 Feb; 133(2):182-6. PubMed ID: 8438059
    [Abstract] [Full Text] [Related]

  • 3. Radiotoxicity of 125I in mammalian cells.
    Kassis AI, Fayad F, Kinsey BM, Sastry KS, Taube RA, Adelstein SJ.
    Radiat Res; 1987 Aug; 111(2):305-18. PubMed ID: 3628718
    [Abstract] [Full Text] [Related]

  • 4. Radiotoxicity of an 125I-labeled DNA intercalator in mammalian cells.
    Kassis AI, Fayad F, Kinsey BM, Sastry KS, Adelstein SJ.
    Radiat Res; 1989 May; 118(2):283-94. PubMed ID: 2727257
    [Abstract] [Full Text] [Related]

  • 5. Radiotoxicity of some iodine-123, iodine-125 and iodine-131-labeled compounds in mouse testes: implications for radiopharmaceutical design.
    Narra VR, Howell RW, Harapanhalli RS, Sastry KS, Rao DV.
    J Nucl Med; 1992 Dec; 33(12):2196-201. PubMed ID: 1460515
    [Abstract] [Full Text] [Related]

  • 6. Kinetics of uptake, retention, and radiotoxicity of 125IUdR in mammalian cells: implications of localized energy deposition by Auger processes.
    Kassis AI, Sastry KS, Adelstein SJ.
    Radiat Res; 1987 Jan; 109(1):78-89. PubMed ID: 3809393
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Radiotoxicity of 5-[123I]iodo-2'-deoxyuridine in V79 cells: a comparison with 5-[125I]iodo-2'-deoxyuridine.
    Makrigiorgos GM, Kassis AI, Baranowska-Kortylewicz J, McElvany KD, Welch MJ, Sastry KS, Adelstein SJ.
    Radiat Res; 1989 Jun; 118(3):532-44. PubMed ID: 2727274
    [Abstract] [Full Text] [Related]

  • 9. Estrogen receptor-directed radiotoxicity with Auger electrons: specificity and mean lethal dose.
    DeSombre ER, Shafii B, Hanson RN, Kuivanen PC, Hughes A.
    Cancer Res; 1992 Oct 15; 52(20):5752-8. PubMed ID: 1394199
    [Abstract] [Full Text] [Related]

  • 10. Chemical modification of 5-[125I]iodo-2'-deoxyuridine toxicity in mammalian cells in vitro.
    Walicka MA, Adelstein SJ, Kassis AI.
    Int J Radiat Biol; 2001 May 15; 77(5):625-30. PubMed ID: 11382341
    [Abstract] [Full Text] [Related]

  • 11. Radionuclides linked to a CD74 antibody as therapeutic agents for B-cell lymphoma: comparison of Auger electron emitters with beta-particle emitters.
    Govindan SV, Goldenberg DM, Elsamra SE, Griffiths GL, Ong GL, Brechbiel MW, Burton J, Sgouros G, Mattes MJ.
    J Nucl Med; 2000 Dec 15; 41(12):2089-97. PubMed ID: 11138697
    [Abstract] [Full Text] [Related]

  • 12. [Kinetics of receptor-mediated radiotoxicity of 16alpha-[125I]-iodostradiol-3,17beta].
    Schomäcker K, Fischer T, Böttcher B, Mraheel SA, Scharl A, Gabruk-Szostak B, Scheidhauer K, Göhring UJ, Meller-Rehbein B, Shukla SK, Schicha H.
    Nuklearmedizin; 1998 Jun 15; 37(4):134-40. PubMed ID: 9650213
    [Abstract] [Full Text] [Related]

  • 13. Radiotoxicity of intranuclear 125I atoms not bound to DNA.
    Commerford SL, Bond VP, Cronkite EP, Reincke U.
    Int J Radiat Biol Relat Stud Phys Chem Med; 1980 May 15; 37(5):547-54. PubMed ID: 6967467
    [Abstract] [Full Text] [Related]

  • 14. 111In-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR.
    Reilly RM, Kiarash R, Cameron RG, Porlier N, Sandhu J, Hill RP, Vallis K, Hendler A, Gariépy J.
    J Nucl Med; 2000 Mar 15; 41(3):429-38. PubMed ID: 10716315
    [Abstract] [Full Text] [Related]

  • 15. Preclinical evaluation of locoregional delivery of radiolabeled iododeoxyuridine and thymidylate synthase inhibitor in a hepatoma model.
    Chi KH, Wang HE, Chen FD, Chao Y, Liu RS, Chou SL, Wang YS, Yen SH.
    J Nucl Med; 2001 Feb 15; 42(2):345-51. PubMed ID: 11216535
    [Abstract] [Full Text] [Related]

  • 16. Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells.
    Ruozi B, Montanari M, Vighi E, Tosi G, Tombesi A, Battini R, Restani C, Leo E, Forni F, Vandelli MA.
    J Liposome Res; 2009 Feb 15; 19(3):241-51. PubMed ID: 19694606
    [Abstract] [Full Text] [Related]

  • 17. Assessment of DNA damage produced by 125I-triplex-forming oligonucleotides in cells.
    Sedelnikova OA, Panyutin IV, Neumann RD, Bonner WM, Panyutin IG.
    Int J Radiat Biol; 2004 Feb 15; 80(11-12):927-31. PubMed ID: 15764404
    [Abstract] [Full Text] [Related]

  • 18. Dosimetry and risk from low- versus high-LET radiation of Auger events and the role of nuclide carriers.
    Feinendegen LE, Neumann RD.
    Int J Radiat Biol; 2004 Feb 15; 80(11-12):813-22. PubMed ID: 15764388
    [Abstract] [Full Text] [Related]

  • 19. Preferential tumor targeting and selective tumor cell cytotoxicity of 5-[131/125I]iodo-4'-thio-2'-deoxyuridine.
    Morgenroth A, Deisenhofer S, Glatting G, Kunkel FH, Dinger C, Zlatopolskiy B, Vogg AT, Kull T, Reske SN.
    Clin Cancer Res; 2008 Nov 15; 14(22):7311-9. PubMed ID: 19010846
    [Abstract] [Full Text] [Related]

  • 20. Effects of intravenous and subcutaneous administration on the pharmacokinetics, biodistribution, cellular uptake and immunostimulatory activity of CpG ODN encapsulated in liposomal nanoparticles.
    Wilson KD, Raney SG, Sekirov L, Chikh G, deJong SD, Cullis PR, Tam YK.
    Int Immunopharmacol; 2007 Aug 15; 7(8):1064-75. PubMed ID: 17570323
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.